CLINICAL_TRIALS
trial_result
· 2012-08-08
Clinical Trial Update: Efficacy of Candesartan on Reducing Blood Pressure in Insulin-Resistant, Obese Patients With Hypertension. [Phase 4]
Summary
Phase 4 trial completed evaluating candesartan for lowering blood pressure in obese, insulin-resistant patients with hypertension.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Takeda | Conditions: Obesity, Hypertension | Phase 4 | Status: COMPLETED